DAVID S GOLDFARB

Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology NEW YORK, NY NPI 1629018908

General Payments — all program years on this page

$93,966.89

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 120
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $24,376.36 across 30 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Alnylam Pharmaceuticals Inc. $9,372.2415
Novo Nordisk AS $7,549.406
Novo Nordisk AS $5,204.728
Retrophin, Inc. $2,250.001

By program year

Program yearAmountRecords
2018 $13,824.4915
2019 $15,724.6033
2020 $4,009.003
2021 $7,698.0210
2022 $9,296.8910
2023 $19,037.5319
2024 $24,376.3630

Records — PY2024 (30)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096552159 Novo Nordisk AS $5,287.50 10/24/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1096552249 Novo Nordisk AS $195.66 10/24/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1096552375 Novo Nordisk AS $740.00 10/24/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1096553079 Novo Nordisk AS $626.71 10/24/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1096553459 Novo Nordisk AS $124.53 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096553471 Novo Nordisk AS $575.00 10/24/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1096598070 Novo Nordisk Inc $121.78 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096795479 Novo Nordisk Inc $267.07 01/23/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1096975744 Novo Nordisk Inc $108.15 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097110719 Novo Nordisk Inc $18.08 10/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097207425 Novo Nordisk Inc $154.24 01/23/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1097485996 Novo Nordisk Inc $372.90 01/23/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1097660913 Novo Nordisk Inc $450.00 01/23/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1097824990 Novo Nordisk Inc $3,712.50 01/23/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1125832635 Alnylam Pharmaceuticals Inc. $145.75 11/08/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1125832637 Alnylam Pharmaceuticals Inc. $64.78 11/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125832639 Alnylam Pharmaceuticals Inc. $10.80 11/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125832641 Alnylam Pharmaceuticals Inc. $10.72 11/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125832643 Alnylam Pharmaceuticals Inc. $48.24 11/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125832645 Alnylam Pharmaceuticals Inc. $7,960.60 11/08/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1125832647 Alnylam Pharmaceuticals Inc. $174.95 11/08/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1125832649 Alnylam Pharmaceuticals Inc. $181.17 11/09/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1125832651 Alnylam Pharmaceuticals Inc. $80.94 11/07/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1125832653 Alnylam Pharmaceuticals Inc. $201.12 11/10/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1125832655 Alnylam Pharmaceuticals Inc. $30.00 11/10/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1125832657 Alnylam Pharmaceuticals Inc. $25.92 11/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125832687 Alnylam Pharmaceuticals Inc. $145.75 11/08/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1125832689 Alnylam Pharmaceuticals Inc. $145.75 11/08/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1125832691 Alnylam Pharmaceuticals Inc. $145.75 11/08/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1149877765 Travere Therapeutics, Inc. $2,250.00 10/15/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.